NCT00722995

Brief Summary

The aim of this study is to assess that the sleeve gastrectomy can improve the risk benefit than the gastric bypass

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
280

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Jan 2008

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 25, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 28, 2008

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

June 15, 2021

Status Verified

June 1, 2021

Enrollment Period

7.3 years

First QC Date

July 25, 2008

Last Update Submit

June 14, 2021

Conditions

Keywords

Morbid obesitySleeve gastrectomyGastric bypassComplicationsEfficacitySafetyCompare

Outcome Measures

Primary Outcomes (1)

  • Composite criteria of morbid/mortality

    during 18 months and 36 months

Secondary Outcomes (8)

  • Frequency of morbid events

    during the follow up

  • Percentage of excess weight loss

    during 18 and 36 months

  • Frequency of patients having a excess weight loss superior than 50%

    during 36 months

  • Regression of morbidities

    during 36 months

  • Rate serum ghrelin

    at inclusion visit, 6, 12, 18 and 36 months

  • +3 more secondary outcomes

Study Arms (2)

1

ACTIVE COMPARATOR

Sleeve gastrectomy

Procedure: Sleeve gastrectomy

2

ACTIVE COMPARATOR

Gastric Bypass

Procedure: Gastric Bypass

Interventions

Laparoscopic sleeve gastrectomy is a restrictive procedure for the treatment for morbid obesity

Also known as: SLEEVE
1

Laparoscopic gastric bypass is a restrictive and difficult absorption procedure for the treatment of morbid obesity

Also known as: BYPASS
2

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patient aged from 18 to 60 years old
  • Patient having given his consent to the use of data from the project
  • Patient presenting one of the following criteria:
  • A morbid obesity strict with BMI\> 40
  • A super obesity BMI\> 50
  • A super super obesity BMI\> 60
  • Obese patient in failure following the installation of a gastric banding with BMI\> 35
  • obese patient 35\>BMI\>40 with a comorbidity
  • Preliminary agreement during the consultation of a psychiatrist / psychologist

You may not qualify if:

  • Patient with complications or co morbidities associated involving life to less 6 months
  • Patient presenting no anaesthetic indication
  • Patient presenting no psychiatric indication for obesity surgery
  • Patient not affiliated with a social security scheme
  • Pregnant Patient likely to breastfeed in the first year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de chirurgie digestive / Centre Hospitalier Général de Saint-Denis Delafontaine

Saint-Denis, 93205, France

Location

MeSH Terms

Conditions

ObesityObesity, Morbid

Interventions

Gastric Bypass

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Bariatric SurgeryBariatricsObesity ManagementTherapeuticsGastroenterostomyAnastomosis, SurgicalSurgical Procedures, OperativeDigestive System Surgical Procedures

Study Officials

  • Jean-Marc CATHELINE, MD, PhD

    Assistance Publique - Hôpitaux de Paris / Hôpital De la Fontaine (St Denis)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2008

First Posted

July 28, 2008

Study Start

January 1, 2008

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

June 15, 2021

Record last verified: 2021-06

Locations